Stock comparison
Edwards Lifesciences
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
EW
Edwards Lifesciences
Market cap
$49.39B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | EW | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 61C | 69B | MTD |
| Benjamin Graham | 89A | 65B | EW |
| Philip Fisher | 62C | 63C | MTD |
| Peter Lynch | 26F | 66B | MTD |
| Joel Greenblatt | 54C | 68B | MTD |
| Charlie Munger | 71C | 74B | MTD |
| Terry Smith | 70B | 70B | Tie |
Side-by-side metrics
| Metric | EW | MTD |
|---|---|---|
| Market cap | $49.39B | $22.29B |
| P/E (TTM) | 43.2x | 25.3x |
| EV/EBIT | 27.6x | 21.6x |
| ROIC (TTM) | 12.06% | 36.09% |
| Gross margin | 78.01% | 57.79% |
| Net margin | 17.34% | 21.4% |
| Revenue CAGR 5y | 3.77% | 2.01% |
| EPS CAGR 5y | -6.52% | 6.12% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
EW leads on
- Market cap$49.39Bvs $22.29B+55%
- Revenue CAGR 5y3.77%vs 2.01%+47%
- Gross margin78.01%vs 57.79%+26%
MTD leads on
- EPS CAGR 5y6.12%vs -6.52%+194%
- Debt / Equity-vs 0.1x+100%
- ROIC (TTM)36.09%vs 12.06%+67%
- P/E (TTM)25.3xvs 43.2x+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.